Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046144
Filing Date
2025-03-27
Accepted
2025-03-27 16:35:23
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tpst-20241231.htm   iXBRL 10-K 2317436
2 EX-4.1 tpst-ex4_1.htm EX-4.1 58398
3 EX-4.2 tpst-ex4_2.htm EX-4.2 118884
4 EX-10.32 tpst-ex10_32.htm EX-10.32 167018
5 EX-10.33 tpst-ex10_33.htm EX-10.33 82374
6 EX-19.1 tpst-ex19_1.htm EX-19.1 73301
7 EX-23.1 tpst-ex23_1.htm EX-23.1 11148
8 EX-31.1 tpst-ex31_1.htm EX-31.1 19863
9 EX-31.2 tpst-ex31_2.htm EX-31.2 20947
10 EX-32.1 tpst-ex32_1.htm EX-32.1 10638
11 GRAPHIC img42883887_0.jpg GRAPHIC 194280
12 GRAPHIC img42883887_1.jpg GRAPHIC 223246
13 GRAPHIC img42883887_2.jpg GRAPHIC 216537
14 GRAPHIC img42883887_3.jpg GRAPHIC 104315
15 GRAPHIC img42883887_4.jpg GRAPHIC 67150
16 GRAPHIC img42883887_5.jpg GRAPHIC 97868
17 GRAPHIC img42883887_6.jpg GRAPHIC 237726
18 GRAPHIC img42883887_7.jpg GRAPHIC 313680
19 GRAPHIC img42883887_8.jpg GRAPHIC 154000
  Complete submission text file 0000950170-25-046144.txt   12943072

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tpst-20241231.xsd EX-101.SCH 1074074
86 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20241231_htm.xml XML 1152349
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35890 | Film No.: 25779978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)